Regeneron Pharmaceuticals Inc (REGN)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 62.48B
P/E Ratio
14.86
Revenue (TTM)
$ 14.21B
Volume
0
52W High
$ 1206.03
52W Low
$ 475.77
Dividend Yield
0.29%
Beta
0.33
Technicals
50-Day MA
550.3752
200-Day MA
637.5513
52 Week High
1206.0297
52 Week Low
475.7676
About REGN
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide.
Employees
15182
Headquarters
Tarrytown, NY
CEO
Dr. Leonard S. Schleifer M.D., Ph.D.
Latest News
Regeneron Pharmaceuticals, Inc. $REGN Shares Sold by APG Asset Management N.V. - MarketBeat
4 hours ago • Google News
Environment, Social and Governance (ESG) Risk Ratings
Total ESG Risk Score
22.33
Percentile: 26.82
Environmental Risk Score
1.51
Percentile: 2
Social Risk Score
13.94
Percentile: 2
Governance Risk Score
5.88
Percentile: 2
Controversy Level
ESG data provided by Sustainalytics, Inc.
REGN
Category Average
2Moderate Controversy Level
NoneSevere